Merit Medical Systems (MMSI)

• Market cap: $5.37B
• 1 day: -0.33%
• 5 days: 0.31%
• 1 month: -10.65%
• 3 months: -14.36%
• 6 months: -0.47%
• Year to date: -1.69%
• 1 year: 27.46%
• 5 years: 131.38%
• 10 years: 386.60%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Employees: 7,400

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

195,569% more call options, than puts

Call options by funds: $93.9M | Put options by funds: $48K

200% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 3 (+2) [Q4]

39% more repeat investments, than reductions

Existing positions increased: 153 | Existing positions reduced: 110

25% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 51

3.14% more ownership

Funds ownership: 101.55% [Q3] → 104.69% (+3.14%) [Q4]

1% more funds holding

Funds holding: 374 [Q3] → 379 (+5) [Q4]

1% more capital invested

Capital invested by funds: $5.82B [Q3] → $5.9B (+$82.7M) [Q4]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $100 6% upside
• Avg. target: $110 16% upside
• High target: $120 27% upside

8 analyst ratings

• positive: 8 100%
• neutral: 0 0%
• negative: 0 0%

Canaccord Genuity Jon Young 38% 1-year accuracy 3 / 8 met price target	14% upside $108	Buy Maintained	25 Apr 2025
Raymond James Jayson Bedford 44% 1-year accuracy 12 / 27 met price target	14% upside $108	Outperform Maintained	25 Apr 2025
Barrington Research Michael Petusky 28% 1-year accuracy 20 / 71 met price target	9% upside $103	Outperform Maintained	25 Apr 2025
Needham Mike Matson 37% 1-year accuracy 44 / 120 met price target	6% upside $100	Buy Maintained	25 Apr 2025
Baird David Rescott 59% 1-year accuracy 10 / 17 met price target	16% upside $110	Outperform Maintained	25 Apr 2025